Mobilization of cutaneous immunity for systemic protection against infections.
This laboratory reported that a single subcutaneous (SC) injection of the natural steroid hormone dehydroepiandrosterone (DHEA) resulted in significant protection against a lethal herpes virus type 2 encephalitis or a systemic coxsackievirus B4 infection. Our previous results have shown that SC injection of DHEA resulted in upregulation of the specific host immune response resulting in protection against a lethal infection. This hormone did not have any direct antiviral effects in vitro. Furthermore, results indicate that, in vivo, DHEA is not the agent directly mediating the upregulation of the immune response. In the skin, DHEA is converted to androstenediol (AED) and it, in turn, is converted to androstenetriol; this is a metabolic process which appears unique to the skin. This report demonstrates that SC injection of AED results in markedly greater resistance against both viral and bacterial infection. Both DHEA and AED appear to function by facilitating and upregulating host immune responses via mobilization of cutaneous immunity to obtain systemic protection against infections. Because these steroids are native to the host and are regulated by the central nervous system, it is suggested that they may be an integral element of neuroimmunomodulation.
Loria
R M
RM
Virginia Commonwealth University, School of Basic Health Sciences, Medical College of Virginia, Richmond 23298.
Padgett
D A
DA
D000734:Androstenediols / Q000008:administration & dosage*; D000818:Animals; D003141:Communicable Diseases / Q000276:immunology*; D003384:Coxsackievirus Infections / Q000517:prevention & control; D003687:Dehydroepiandrosterone / Q000008:administration & dosage*; D013293:Enterococcus faecalis / Q000276:immunology; D029822:Enterovirus B, Human; D007113:Immunity, Innate; D051379:Mice; D012867:Skin / Q000276:immunology*
D000734:Androstenediols; D003687:Dehydroepiandrosterone